Central Drugs Standard Control Organisation has granted market authorisation for NexCAR19, India’s first indigenously-developed Chimeric Antigen Receptor T cell Therapy
Central Drugs Standard Control Organisation (CDSCO) has granted market authorisation for NexCAR19, India’s first indigenously-developed Chimeric Antigen Receptor T cell…